Resolved to issue and grant 187 stock-based compensation options to two directors (foreign directors excluded), comprising 18,700 shares of common stock as the target shares, with 100 shares per option. Grant date: 2026\/09\/15; exercise period: 2026\/09\/16 to 2056\/09\/15. Exercise price set at fair value on grant date, rounding down fractions, capital increase capped at half.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"8281","jir_company_name":"Xebio Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-18","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/8281-20260818-01.pdf","jir_short_summary":"Resolved to issue and grant 187 stock-based compensation options to two directors (foreign directors excluded), comprising 18,700 shares of common stock as the target shares, with 100 shares per option. Grant date: 2026\/09\/15; exercise period: 2026\/09\/16 to 2056\/09\/15. Exercise price set at fair value on grant date, rounding down fractions, capital increase capped at half.","jir_summary":"### Issuance of Stock Acquisition Rights\nAt today\u2019s Board of Directors meeting, to strengthen the linkage between director remuneration and corporate value, we resolved to\u52df\u96c6\u4e8b\u9805 for stock-based compensation options and decided to grant them. The targets are two directors (excluding external directors), total 187 units, 100 shares per unit, and 18,700 shares of common stock. The exercise period is 2026\/09\/16\u20132056\/09\/15, and the exercise price is the amount obtained by multiplying the fair value on the grant date by 1 yen per share.\n\n### Conditions \/ Adjustments\nThe exercise of the stock acquisition rights requires payment of the fair value calculated by the Black-Scholes model. There are various adjustments and conditions, including adjustments for stock splits and reverse splits, and capital increase limits capped at half of the increase in capital. Other conditions during the exercise period follow agreements based on resolutions by the shareholders meeting and the Board of Directors.","jir_financial_highlights":"Total number of stock acquisition rights: 187 units (Unknown)\nTarget shares: 18,700 shares (Unknown)\nExercise period: From September 16, 2026 to September 15, 2056 (Unknown)","jir_category":"","jir_hashtags":"#XebioHoldings, #StockBasedCompensationOptions","jir_key_figures":"Total number of stock acquisition rights: 187 units\nTarget shares: 18,700 shares\nExercise period: 2026\/09\/16\u20132056\/09\/15","jir_meta_title":"Xebio Holdings: Notice of Stock-Based Compensation Option Grant | August 2026","jir_meta_description":"Xebio Holdings issues and grants 187 stock-based compensation options to two directors. Exercise period is 2026\/09\/16\u20132056\/09\/15. Payment at fair value with adjustments.","jir_og_title":"Notice Regarding Grant of Stock-Based Compensation Options (Xebio Holdings)","jir_og_description":"Xebio Holdings grants 187 stock-based compensation options to two directors. Details on exercise period, payment method, and adjustment conditions.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17366,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-105130","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n